Home and Not Alone: Fresenius Medical Care North America
https://fmcna.com/company/our-company/news-releases/80-percent-nx2me-adoption/
WEBWALTHAM, Mass., Sept. 8, 2021 -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, today announced that 80 percent of all NxStage home hemodialysis (HHD) patients now regularly use the company's Nx2me Connected Health platform, with adoption increasing more than 44 percent in the past year.
DA: 43 PA: 97 MOZ Rank: 9